Latest Undisclosed Funding Rounds
Funding announcements whose series or stage was not named. Round amounts and investor roles are shown where disclosed.
- Rounds
- 2,305 All time
- Disclosed funding
- $375.2B 1239 disclosed amounts
- Median round
- $8.9M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| VI Viridian Ingni PropulsionCompany profile Viridian Ingni Propulsion develops electric motors and controllers using rare-earth-free and magnet-free technologies for vehicle manufacturers. Viridian Ingni Propulsion develops electric motors and controllers using rare-earth-free and magnet-free technologies for vehicle manufacturers. | Undisclosed | SIPCOT Industrial Innovation and Scale-up GrantUndisclosed | Industrial tech | India | Investors | |
| AM Archeon MedicalCompany profile Archeon Medical develops ventilation feedback devices that help emergency responders measure and adjust manual ventilation during resuscitation. Archeon Medical develops ventilation feedback devices that help emergency responders measure and adjust manual ventilation during resuscitation. | Undisclosed | Undisclosed | Healthtech | France | Investors | |
| R RivianCompany profile Electric vehicle manufacturer developing vehicles, electrical architecture and software. Electric vehicle manufacturer developing vehicles, electrical architecture and software. | $1B | Convertible noteUndisclosed | Mobility | United States | Investors | |
| SA Stability AICompany profile Builds generative AI creative tools for music, gaming and entertainment professionals Builds generative AI creative tools for music, gaming and entertainment professionals | ~$80M | Recapitalisation investmentUndisclosed | AI | United States | Investors | |
| Q QpiAI develops quantum-computing systems and AI software for enterprises. | $6.5M | Pre-Series AUndisclosed | Hardware | India | Investors | |
| RB Revascular Bio Co., Ltd.Company profile Revascular Bio develops cell therapies using vascular endothelial stem cells. Revascular Bio develops cell therapies using vascular endothelial stem cells. | Undisclosed | AMED drug-discovery ecosystem grantUndisclosed | Biotech | Japan | Investors | |
| M MUSE develops Armo, a multi-purpose robot for retail stores. | ¥570M | Undisclosed | Robotics | Japan | Investors | |
| AT Alchemab TherapeuticsCompany profile Alchemab Therapeutics develops antibody medicines by studying people resilient to disease. Alchemab Therapeutics develops antibody medicines by studying people resilient to disease. | $595K | Parkinson research grantUndisclosed | Biotech | United Kingdom | Investors | |
| DT Delix TherapeuticsCompany profile Delix Therapeutics develops neuroplastogen medicines for psychiatric and neurological disorders. Delix Therapeutics develops neuroplastogen medicines for psychiatric and neurological disorders. | $825K | Department of Defense research grantUndisclosed | Biotech | United States | Investors | |
| C CoComplyCompany profile CoComply helps organisations identify, classify and govern external workers across contractors, agencies and supplier agreements. CoComply helps organisations identify, classify and govern external workers across contractors, agencies and supplier agreements. | Undisclosed | Innovate UK Smart GrantUndisclosed | Enterprise software | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Innovate UK
Emerald, Go Eve, Nearhuman
39rounds0led - 2NVIDIA
Noeri, Applied Compute, Riverlane
32rounds1led - 3Bethnal Green Ventures
Excelas, HeyLina, Amytis
25rounds0led - 4Future of Health Grant
Healium, NeuroTreasure Solutions, Entrelacs
20rounds0led - 5Peak XV Partners
PowerUp Money, Hex, Meragi
19rounds3led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.